Wednesday, November 13, 2024
- Advertisement -spot_img

TAG

Johnson & Johnson's

US FDA expands J&J’s psoriasis drug Tremfya for inflammatory bowel disease | World News

In a late-stage trial, patients receiving Tremfya were able to achieve endoscopic remission a state where no signs of inflammation, ulcers or bleeding...

Latest news

- Advertisement -spot_img